Qingdao Vland Biotech INC
SSE:603739
Qingdao Vland Biotech INC
SSE:603739
Price:
16.04
CNY
0.19%
Market Closed
Market Cap:
¥4.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Qingdao Vland Biotech INC
SSE:603739
|
CN |
|
Shoe Carnival Inc
NASDAQ:SCVL
|
US |
|
Polski Koncern Naftowy Orlen SA
WSE:PKN
|
PL |
|
R
|
RPG Life Sciences Limited
NSE:RPGLIFE
|
IN |
|
T
|
Toyo Asano Foundation Co Ltd
TSE:5271
|
JP |
|
Centrica PLC
LSE:CNA
|
UK |
Income Statement
Earnings Waterfall
Qingdao Vland Biotech INC
Qingdao Vland Biotech INC
Income Statement
Qingdao Vland Biotech INC
Qingdao Vland Biotech INC
Currency: CNY
| Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||
| Interest Expense |
4
|
4
|
4
|
4
|
2
|
2
|
2
|
2
|
2
|
3
|
0
|
3
|
2
|
3
|
4
|
7
|
7
|
8
|
10
|
10
|
15
|
18
|
20
|
22
|
22
|
0
|
0
|
0
|
|
| Revenue |
814
N/A
|
808
-1%
|
824
+2%
|
840
+2%
|
847
+1%
|
870
+3%
|
884
+2%
|
922
+4%
|
960
+4%
|
1 030
+7%
|
1 078
+5%
|
1 100
+2%
|
1 151
+5%
|
1 141
-1%
|
1 134
-1%
|
1 148
+1%
|
1 163
+1%
|
1 140
-2%
|
1 175
+3%
|
1 213
+3%
|
1 199
-1%
|
1 253
+5%
|
1 264
+1%
|
1 265
+0%
|
1 321
+4%
|
1 344
+2%
|
1 364
+1%
|
1 391
+2%
|
|
| Gross Profit | |||||||||||||||||||||||||||||
| Cost of Revenue |
(410)
|
(420)
|
(430)
|
(440)
|
(438)
|
(452)
|
(457)
|
(468)
|
(496)
|
(543)
|
(578)
|
(606)
|
(620)
|
(631)
|
(635)
|
(658)
|
(663)
|
(654)
|
(671)
|
(681)
|
(648)
|
(684)
|
(690)
|
(696)
|
(728)
|
(752)
|
(761)
|
(776)
|
|
| Gross Profit |
404
N/A
|
388
-4%
|
394
+2%
|
400
+2%
|
409
+2%
|
418
+2%
|
427
+2%
|
455
+7%
|
464
+2%
|
487
+5%
|
500
+3%
|
494
-1%
|
530
+7%
|
510
-4%
|
499
-2%
|
489
-2%
|
500
+2%
|
486
-3%
|
504
+4%
|
533
+6%
|
550
+3%
|
569
+3%
|
574
+1%
|
569
-1%
|
592
+4%
|
592
0%
|
603
+2%
|
615
+2%
|
|
| Operating Income | |||||||||||||||||||||||||||||
| Operating Expenses |
(293)
|
(282)
|
(293)
|
(309)
|
(317)
|
(310)
|
(317)
|
(320)
|
(323)
|
(336)
|
(342)
|
(337)
|
(363)
|
(357)
|
(358)
|
(366)
|
(396)
|
(394)
|
(408)
|
(422)
|
(426)
|
(437)
|
(435)
|
(433)
|
(454)
|
(450)
|
(467)
|
(476)
|
|
| Selling, General & Administrative |
(224)
|
(224)
|
(236)
|
(248)
|
(260)
|
(267)
|
(275)
|
(280)
|
(257)
|
(279)
|
(280)
|
(274)
|
(285)
|
(294)
|
(292)
|
(302)
|
(303)
|
(315)
|
(326)
|
(331)
|
(311)
|
(340)
|
(340)
|
(341)
|
(319)
|
(352)
|
(364)
|
(367)
|
|
| Research & Development |
(64)
|
(70)
|
(73)
|
(78)
|
(69)
|
(74)
|
(75)
|
(74)
|
(73)
|
(86)
|
(91)
|
(96)
|
(92)
|
(103)
|
(104)
|
(99)
|
(94)
|
(101)
|
(104)
|
(111)
|
(100)
|
(115)
|
(114)
|
(111)
|
(103)
|
(120)
|
(127)
|
(137)
|
|
| Depreciation & Amortization |
(17)
|
0
|
0
|
0
|
(18)
|
0
|
0
|
0
|
(21)
|
0
|
0
|
0
|
(24)
|
0
|
0
|
0
|
(29)
|
0
|
0
|
0
|
(36)
|
0
|
0
|
0
|
(58)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
13
|
12
|
17
|
18
|
30
|
31
|
33
|
34
|
28
|
29
|
29
|
33
|
38
|
40
|
38
|
35
|
30
|
23
|
22
|
21
|
21
|
17
|
19
|
19
|
26
|
22
|
23
|
28
|
|
| Operating Income |
112
N/A
|
106
-5%
|
101
-4%
|
91
-10%
|
92
+0%
|
107
+17%
|
110
+3%
|
135
+22%
|
141
+5%
|
151
+7%
|
158
+5%
|
157
-1%
|
167
+6%
|
152
-9%
|
141
-8%
|
124
-12%
|
104
-16%
|
93
-11%
|
96
+4%
|
111
+15%
|
125
+12%
|
131
+5%
|
139
+6%
|
135
-3%
|
138
+2%
|
142
+3%
|
136
-5%
|
139
+2%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||
| Interest Income Expense |
(2)
|
(2)
|
1
|
4
|
7
|
9
|
7
|
5
|
2
|
1
|
2
|
4
|
5
|
4
|
4
|
3
|
0
|
0
|
(2)
|
(4)
|
3
|
(1)
|
(6)
|
(12)
|
(13)
|
(16)
|
(13)
|
12
|
|
| Non-Reccuring Items |
(1)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(4)
|
1
|
1
|
1
|
(1)
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
|
| Total Other Income |
3
|
8
|
6
|
7
|
(0)
|
(6)
|
(7)
|
(7)
|
(1)
|
(1)
|
(1)
|
(0)
|
1
|
1
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(2)
|
|
| Pre-Tax Income |
112
N/A
|
112
N/A
|
109
-2%
|
102
-7%
|
98
-4%
|
110
+13%
|
111
+1%
|
133
+20%
|
140
+5%
|
151
+8%
|
159
+5%
|
161
+2%
|
171
+6%
|
157
-9%
|
145
-7%
|
125
-13%
|
102
-19%
|
93
-9%
|
94
+2%
|
108
+14%
|
122
+14%
|
131
+7%
|
133
+2%
|
124
-7%
|
123
-1%
|
125
+1%
|
121
-3%
|
149
+23%
|
|
| Net Income | |||||||||||||||||||||||||||||
| Tax Provision |
(19)
|
(18)
|
(18)
|
(12)
|
(8)
|
(8)
|
(9)
|
(16)
|
(18)
|
(20)
|
(19)
|
(18)
|
(21)
|
(21)
|
(21)
|
(19)
|
(17)
|
(14)
|
(14)
|
(17)
|
(20)
|
(23)
|
(25)
|
(27)
|
(31)
|
(34)
|
(32)
|
(35)
|
|
| Income from Continuing Operations |
93
|
94
|
91
|
89
|
89
|
102
|
102
|
117
|
122
|
131
|
140
|
144
|
150
|
136
|
124
|
107
|
85
|
78
|
80
|
90
|
103
|
107
|
108
|
97
|
92
|
92
|
90
|
114
|
|
| Income to Minority Interest |
(10)
|
(10)
|
(10)
|
(10)
|
(12)
|
(13)
|
(13)
|
(14)
|
(13)
|
(15)
|
(14)
|
(13)
|
(18)
|
(14)
|
(15)
|
(14)
|
(16)
|
(16)
|
(16)
|
(19)
|
(22)
|
(25)
|
(30)
|
(31)
|
(30)
|
(32)
|
(30)
|
(30)
|
|
| Net Income (Common) |
83
N/A
|
84
+0%
|
81
-3%
|
79
-3%
|
78
-1%
|
89
+15%
|
89
N/A
|
103
+15%
|
109
+6%
|
116
+7%
|
126
+9%
|
130
+3%
|
133
+2%
|
122
-8%
|
109
-11%
|
92
-15%
|
70
-24%
|
62
-11%
|
64
+3%
|
71
+11%
|
81
+14%
|
83
+3%
|
79
-5%
|
66
-16%
|
63
-5%
|
59
-5%
|
60
+1%
|
84
+39%
|
|
| EPS (Diluted) |
0.51
N/A
|
0.4
-22%
|
0.39
-3%
|
0.36
-8%
|
0.36
N/A
|
0.41
+14%
|
0.4
-2%
|
0.46
+15%
|
0.5
+9%
|
0.53
+6%
|
0.49
-8%
|
0.51
+4%
|
0.54
+6%
|
0.48
-11%
|
0.45
-6%
|
0.37
-18%
|
0.28
-24%
|
0.25
-11%
|
0.26
+4%
|
0.28
+8%
|
0.32
+14%
|
0.33
+3%
|
0.31
-6%
|
0.26
-16%
|
0.25
-4%
|
0.24
-4%
|
0.24
N/A
|
0.33
+38%
|
|
Switch to:
Switch to:
See Also
Discover More
